Institut Gustave Roussy
The Institut Gustave Roussy (IGR ) is a French institute profit organizations in the research and treatment of cancer. Headquarters of the Institute is Villejuif, near Paris.
History
In 1921, by the pathologist and rector of the Academy of Paris Gustave Roussy ( 1874-1948 ), the Hôpital Paul Brousse - founded specifically for the treatment of cancers in Villejuif. On November 14, 1925, the establishment of a regional cancer center for the surrounding area of Paris ( " lutte contre le Centre régional de cancer de la banlieue parisienne ") was decreed by the Conseil général de la Seine and Professor Roussy was on November 17, the first director appointed. By another decree of 12 May 1926, the regional cancer center in Villejuif in an Institute for Cancer Research of the Faculty of Medicine in Paris ( " Institut du Cancer de la Faculté de Médecine de Paris " ) was converted. The Institute initially divided into a research unit ( Institut du Cancer ) with an attached hospital ( Section hospitalière ). It was given on 6 November 1927 profit status. For the institution was the newly created Fondation pour le Développement de l'Institut du Cancer de la Faculté de Paris ( " Foundation for Development of the Cancer Research Institute of the Faculty of Paris "). On March 17, 1930 a new section of the laboratoires ( research laboratory area) was opened by the President of the Republic Gaston Doumergue.
- Images of 1934
- Entrance
- Operating room
- Address by G. Roussy
- President Lebrun (left) and G. Roussy (center)
After the death of the founder Roussy Institute in 1949 René Huguenin been appointed director of the Institut du cancer and Charles Oberling Head of the laboratory area. In 1950 the Institute was officially renamed Institut Gustave Roussy. In the following years, research focused at the Institute in various areas, including pediatric oncology ( on the initiative of Odile Schweisguth ) and the treatment with radioisotopes ( here was a leader Maurice Tubiana ). In the 1950s, the Institute has been continuously strengthened. There were added to animal testing facilities, as well as departments of Radiotherapy, epidemiology, cell culture, virology and pharmacology. In 1976, the foundations were to a new hospital complex, which could be put into operation in April 1980, set. Further extensions ( magnetic resonance imaging, patient building, research pavilion) were made in the 1970s to the 1990s.
Directors of the IGR
- Gustave Roussy, 1921-1947
- René Huguenin, 1947-1955
- Pierre Denoix, 1956-1982
- Yves Cachin, 1974-1978 ( Interim Directorate )
- Maurice Tubiana, 1982-1988
- Robert Flamant, 1988-1994
- Thomas Tursz, 1994-2010
- Alexander Eggermont, since 2010
Self-understanding ( "mission" ) of the Institute
The IGR sees itself as a center of excellence and innovation in cancer research. The aim of the research is to improve the treatment and in-depth understanding of the fundamentals of carcinogenesis. On the one hand, takes place in basic biomedical research, on the other clinical studies are conducted to new treatments and drugs test. Locally, virtually all modern treatment modalities of cancer treatment available, ranging from surgery, for diagnostic and interventional radiology and radiotherapy, to modern laboratory diagnostics and medical oncology. In addition, the IGR has an education function and operates in cooperation with the University of Paris-Sud an École de Cancérologie the training of oncologists. There are numerous scientific collaborations, including with the National Cancer Center in Tokyo, the MD Anderson Cancer Center in Houston, the Karolinska Institutet in Stockholm and the Memorial Sloan -Kettering Cancer Center in New York.
Pay
In 2007, the IGR had a budget of € 216 million, of which € 38 million was spent on research. It worked in 2100 medical professionals there, as well as 300 researchers in 14 research institutions. There were 10,711 new patients, 142,000 patients consultations, 10,470 treatments and 43,000 follow-up treatments. The Institute had 368 patient beds.